# Myo-inositol Versus Metformin Administration in Post-menopausal Women With Metabolic Syndrome

> **NCT01046500** · PHASE2 · UNKNOWN · sponsor: **University of Messina** · enrollment: 100 (estimated)

## Conditions studied

- Metabolic Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** myo-inositol
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01046500
- **Lead sponsor:** University of Messina
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2014-06
- **Final completion:** 2014-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2014-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01046500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01046500, "Myo-inositol Versus Metformin Administration in Post-menopausal Women With Metabolic Syndrome". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT01046500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*